Financings in Brief: CardioThoracic Systems
This article was originally published in The Gray Sheet
Executive Summary
CardioThoracic Systems: Developer of the Minimally Invasive Direct Coronary Artery Bypass (MIDCAB) system begins NASDAQ trading following initial public offering of 5.1 mil. shares of common stock for $18 per share. The offering was larger than anticipated by CTS, which indicated plans to offer 3.8 mil. shares when it filed a registration statement with SEC in March ("The Gray Sheet" March 11, p. 19)...